Market cap
₹204 Cr
Revenue (TTM)
₹34 Cr
P/E Ratio
40.3
P/B Ratio
6.5
Div. Yield
0 %
Quality Score
9/10
Growth Score
6/10
Valuation Score
6/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
27.7 %
-
ROCE
30.2 %
-
Industry P/E
55.07
-
EV/EBITDA
28.3
-
Debt to Equity
0.1
-
Book Value
₹43.6
-
EPS
₹7
-
Face value
10
-
Shares outstanding
7,240,000
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Accretion Nutraveda
| -- | -0.7 | 6.8 | -- | -- | -- | -- |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Accretion Nutraveda
|
281.9 | 204.1 | 33.6 | 5.1 | -- | 27.7 | 40.3 | 6.5 |
| 1,350.2 | 16,589.5 | 2,590.4 | 603.0 | 29.3 | 19.6 | 27.5 | 4.8 | |
| 577.7 | 10,912.7 | 885.7 | 234.9 | 27.8 | 18 | 46.5 | 4.9 | |
| 1,481.1 | 15,506.7 | 1,108.4 | 270.2 | 28.3 | 14.5 | 56.3 | 7.5 | |
| 1,869.4 | 35,497.5 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 35.1 | 6.8 | |
| 23,205.0 | 29,798.0 | 2,371.8 | 497.8 | 28.0 | 28.5 | 59.9 | 14.7 | |
| 975.6 | 5,827.4 | 942.6 | 9.9 | 0.3 | 1.2 | 672.4 | 4.5 | |
| 1,482.1 | 6,826.8 | 691.7 | 130.8 | 24.5 | 14.5 | 54 | 7.1 | |
| 1,152.1 | 13,020.2 | 675.6 | 183.6 | 32.2 | 22.7 | 71.3 | 14.1 | |
| 365.0 | 10,310.7 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 18.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Accretion Nutraveda
--
-
Incorporated
2021
-
Chairman
Harshad Nanubhai Rathod
-
Managing Director
Mayur Popatlal Sojitra
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Accretion Nutraveda Ltd’s IPO? Explore our IPO Details page.
FAQs for Accretion Nutraveda
What is the current share price of Accretion Nutraveda Ltd Today?
The share price of Accretion Nutraveda Ltd is ₹281.90 (BSE) as of 28-Aug-2026 IST. Accretion Nutraveda Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Accretion Nutraveda Ltd?
The P/E ratio of Accretion Nutraveda Ltd is 40.27 times as on 28-Aug-2026, a 27 discount to its peers’ median range of 55.07 times.
The P/B ratio of Accretion Nutraveda Ltd is 6.47 times as on 28-Aug-2026, a 36 premium to its peers’ median range of 4.76 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
29.71 |
4.77 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2026 |
29.71 |
4.77 |
What is the 52 Week High and Low of Accretion Nutraveda Ltd?
The 52-week high and low of Accretion Nutraveda Ltd are Rs 313.00 and Rs 150.10 as of 31-Aug-2026.
What is the market cap of Accretion Nutraveda Ltd?
Accretion Nutraveda Ltd has a market capitalisation of ₹ 204 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Accretion Nutraveda Ltd?
Before investing in Accretion Nutraveda Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.